The Regulation of the Inflammatory Response Through Nuclear Factor-κB Pathway by Angiotensin IV Extends the Role of the Renin Angiotensin System in Cardiovascular Diseases

Trends in Cardiovascular Medicine

Volumn 17, Issue 1, 2007, Pages 19-25

  Ruiz Ortega, Marta ^a   Esteban, Vanesa ^a   Egido, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; MICROSOMAL AMINOPEPTIDASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1;

CARDIOVASCULAR DISEASE; ENDOTHELIUM CELL; HORMONE ACTION; HUMAN; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOOTH MUSCLE FIBER; THROMBOGENESIS; TISSUE INJURY; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; NF-KAPPA B; RENIN-ANGIOTENSIN SYSTEM; VASCULITIS;

EID: 33845957564     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.10.003     Document Type: Review

References (46)

1. Albiston A.L., McDowall S.G., Matsacos D., et al. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276 (2001) 48623-48626
2. Ardaillou R. Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. Curr Opin Nephrol Hypertens 6 (1997) 28-34
3. Chai S.Y., Fernando R., Peck G., et al. The angiotensin IV/AT4 receptor. Cell Mol Life Sci 61 (2004) 2728-2737
4. Chen J.K., Zimpelmann J., Harris R.C., and Burns K.D. Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am J Physiol 280 (2001) F980-F988
5. Chen S., Patel J., and Block E.R. Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release. Am J Physiol 279 (2000) L849-L856
6. Daugherty A., Rateri D.L., Lu H., et al. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 21;110 (2004) 3849-3857
7. De Gasparo M., Catt K.J., Inagami T., et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52 (2000) 415-472
8. Diet F., Pratt R.E., Berry G.J., et al. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94 (1996) 2756-2767
9. Esteban V., Ruperez M., Sanchez-Lopez E., Rodriguez-Vita J., Lorenzo O., et al. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Circ Res 96 9 (2005) 965-973
10. Ferreira A.J., and Santos R.A. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res 38 (2005) 499-507
11. Fukasawa K., Fujii H., Saitoh Y., et al. Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis. Cancer Lett 243 (2006) 135-143
12. Gesualdo L., Ranieri E., Monno R., et al. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney Int 56 (1999) 461-470
13. Hall K.L., Hanesworth J.M., Ball A.E., et al. Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pept 44 (1993) 225-232
14. Hall K.L., Venkateswaran S., Hanesworth J.M., et al. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept 58 (1995) 107-115
15. Handa R.K., Krebs L.T., Harding J.W., et al. Angiotensin IV AT4-receptor system in the rat kidney. Am J Physiol 274 (1998) F290-F299
16. Keller S.R. Role of the insulin-regulated aminopeptidase IRAP in insulin action and diabetes. Biol Pharm Bull 27 (2004) 761-764
17. Kerins D.M., Hao Q., and Vaughn D.E. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 96 (1995) 2515-2520
18. Kramar E.A., Harding J.W., and Wrigh J.W. Angiotensin II and IV-induced changes in cerebral blood flow: roles of AT1, AT2 and AT4 receptor subtypes. Regul Pept 68 (1997) 131-138
19. Krebs L.T., Kramár E.A., Hanesworth J.M., et al. Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist. Regul Pept 67 (1996) 123-130
20. Lawnicka H., Potocka A.M., Juzala A., et al. Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer in vitro. Med Sci Monit 10 (2004) BR410-BR413
21. Lendeckel U., Arndt M., Wrenger S., et al. Expression and activity of ectopeptidases in fibrillating human atria. J Mol Cell Cardiol 33 (2001) 1273-1281
22. Lew R.A., Mustafa T., McDowall S.G., et al. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J Neurochem 86 (2003) 344-350
23. Li Y.D., Block E.R., and Patel J.M. Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol 283 (2002) L707-L716
24. Lu J., Zhang J., Block E.R., and Patel J.M. Angiotensin IV enhances phosphorylation of 4EBP1 by multiple signaling events in lung endothelial cells. Mol Cell Biochem 275 (2005) 181-188
25. Meier P., Maillard M., and Burnier M. The future of angiotensin II inhibition in cardiovascular medicine. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 15-30
26. Moeller I., Clune E.F., Fennessy P.A., et al. Up-regulation of AT4 receptor levels in carotid arteries following balloon injury. Regul Pept 83 (1999) 25-30
27. Monaco C., and Paleolog E. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 61 (2004) 671-682
28. Olivo Rdo A., Teixeira Cde F., and Silveira P.F. Representative aminopeptidases and prolyl endopeptidase from murine macrophages: comparative activity levels in resident and elicited cells. Biochem Pharmacol 69 (2005) 1441-1450
29. Olsen J., Kokholm K., Noren O., et al. Structure and expression of aminopeptidase. N Adv Exp Med Biol 421 (1997) 47-57
30. Petrescu G., Costuleanu M., Slatineanu S.M., et al. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity. J Renin Angiotensin Aldosterone Syst 2 (2001) 180-187
31. Pilar Carrera M., Ramirez-Exposito M.J., Duenas B., et al. Insulin-regulated aminopeptidase/placental leucil aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. Anticancer Res 26 (2006) 1011-1014
32. Remuzzi G., Perico N., Macia M., et al. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 99 (2005) S57-S65
33. Ruiz-Ortega M., Esteban V., Ruperez M., et al. Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 15 (2006) 159-166
34. Ruiz-Ortega M., Lorenzo O., and Egido J. Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts. Kidney Int Suppl 68 (1998) S41-S45
35. Ruiz-Ortega M., Lorenzo O., and Egido J. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells. Kidney Int 57 (2000) 2285-2298
36. Ruiz-Ortega M., Lorenzo O., Ruperez M., et al. Role of AT1 and AT2 receptors in angiotensin II-induced nuclear transcription factor κB activation in vascular smooth muscle cells. Circ Res 86 (2000) 1266-1272
37. Sano M., Itakura A., Ito M., et al. Placental leucine aminopeptidase might regulate the effects of oxytocin with resolution in endothelial cells. Med Sci Monit 11 (2005) BR195-BR199
38. Santos R.A., Simoes e Silva A.C., Maric C., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100 (2003) 8258-8263
39. Sato Y. Role of aminopeptidase in angiogenesis. Biol Pharm Bull 27 (2004) 772-776
40. Schieffer B., Schieffer E., Hilfiker-Kleiner D., et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 101 (2000) 1372-1378
41. Sihn G., Savary K., Michaud A., et al. Aminopeptidase N during the ontogeny of the chick. Differentiation 74 (2006) 119-128
42. Stragier B., Clinckers R., Meurs A., et al. Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats. J Neurochem 98 (2006) 1100-1113
43. Thomas W.G., and Mendelsohn F.A. Angiotensin receptors: form and function and distribution. Int J Biochem Cell Biol 35 (2003) 774-779
44. Vauquelin G., Michotte Y., Smolders I., et al. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. J Renin Angiotensin Aldosterone Syst 3 (2002) 195-204
45. Wang L., Eberhard M., and Erne P. Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblast by angiotensin IV. Clin Sci 88 (1995) 557-562
46. Wright J.W., Krebs L.T., Stobb J.W., et al. The angiotensin IV system: functional implications. Front Neuroendocrinol 16 (1995) 23-52